Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of UnitedHealth Group’s (UNH) Q2 2023 earnings
Diversified healthcare company UnitedHealth Group (NYSE: UNH) reported higher earnings and revenues for the second quarter of 2023. The company also raised its full-year earnings guidance.
Second-quarter revenues grew 16% year-over-year to $92.9 billion, reflecting strong growth across all business segments. Net earnings attributable to shareholders rose to $5.47 billion or $5.82 per share in Q2 from $5.07 billion or $5.34 per share in the same period of 2022.
Adjusted earnings, excluding special items, increased 10% annually to $6.14 per share. UnitedHealth raised the range of its full-year net earnings forecast to $23.45 to $23.75 per share and adjusted earnings per share guidance to $24.70 to $25.00 per share.
“Our diverse healthcare capabilities and dedicated colleagues are enabling us to meet the needs of more people in more ways, driving substantial growth and expanding our opportunities to serve well into the future,” said Andrew Witty, the company’s chief executive officer.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Nike (NKE) looks set to beat hurdles and build a brighter future
Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business
Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company
Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications
